Table 5.
Parameter | CIK/DC–CIK
|
CIK/DC–CIK
|
Analysis method | Heterogeneity
|
OR | 95% CI | P-value | |
---|---|---|---|---|---|---|---|---|
After treatment (n) | Before treatment (n) | I2 (%) | P-value | |||||
AgNOR | 50 | 50 | Random | 67 | 0.08 | 1.05 | 0.40 to 1.70 | 0.002 |
IFN-γ | 26 | 26 | Random | 33.91 | 30.68 to 37.14 | <0.00001 | ||
IL-2 | 86 | 86 | Random | 97 | <0.00001 | 19.56 | 9.74 to 29.39 | <0.0001 |
IL-4 | 26 | 26 | Random | −8.34 | −10.06 to −6.62 | <0.00001 | ||
IL-6 | 30 | 30 | Random | −35.01 | −59.02 to −11.00 | 0.004 | ||
IL-10 | 26 | 26 | Random | −11.10 | −13.13 to −9.07 | <0.00001 | ||
IL-12 | 24 | 24 | Random | 12.25 | 1.53 to 22.97 | 0.03 | ||
TGF-β | 56 | 56 | Random | 0 | 0.34 | −0.35 | −0.58 to −0.13 | 0.002 |
Abbreviations: AgNOR, silver-staining nucleolar organizer region; CI, confidence interval; CIK, cytokine-induced killer cells; DC–CIK, dendritic cells and CIK; OR, odds ratio.